vs

Side-by-side financial comparison of AvalonBay Communities (AVB) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

AvalonBay Communities is the larger business by last-quarter revenue ($767.9M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). AvalonBay Communities runs the higher net margin — 9040.6% vs -10.1%, a 9050.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 3.7%). AvalonBay Communities produced more free cash flow last quarter ($1.4B vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.8%).

AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

AVB vs CLOV — Head-to-Head

Bigger by revenue
AVB
AVB
1.6× larger
AVB
$767.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+41.0% gap
CLOV
44.7%
3.7%
AVB
Higher net margin
AVB
AVB
9050.7% more per $
AVB
9040.6%
-10.1%
CLOV
More free cash flow
AVB
AVB
$1.5B more FCF
AVB
$1.4B
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.8%
AVB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVB
AVB
CLOV
CLOV
Revenue
$767.9M
$487.7M
Net Profit
$166.0M
$-49.3M
Gross Margin
Operating Margin
64.2%
-10.1%
Net Margin
9040.6%
-10.1%
Revenue YoY
3.7%
44.7%
Net Profit YoY
-41.2%
-123.2%
EPS (diluted)
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVB
AVB
CLOV
CLOV
Q4 25
$767.9M
$487.7M
Q3 25
$766.8M
$496.6M
Q2 25
$760.2M
$477.6M
Q1 25
$745.9M
$462.3M
Q4 24
$740.5M
$337.0M
Q3 24
$734.3M
$331.0M
Q2 24
$726.0M
$356.3M
Q1 24
$712.9M
$346.9M
Net Profit
AVB
AVB
CLOV
CLOV
Q4 25
$166.0M
$-49.3M
Q3 25
$381.3M
$-24.4M
Q2 25
$268.7M
$-10.6M
Q1 25
$236.6M
$-1.3M
Q4 24
$282.1M
$-22.1M
Q3 24
$372.5M
$-9.2M
Q2 24
$253.9M
$7.4M
Q1 24
$173.4M
$-19.2M
Gross Margin
AVB
AVB
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
AVB
AVB
CLOV
CLOV
Q4 25
64.2%
-10.1%
Q3 25
65.7%
-4.9%
Q2 25
67.6%
-2.2%
Q1 25
68.5%
-0.3%
Q4 24
63.1%
-6.4%
Q3 24
65.4%
-2.7%
Q2 24
66.6%
2.0%
Q1 24
67.2%
-6.5%
Net Margin
AVB
AVB
CLOV
CLOV
Q4 25
9040.6%
-10.1%
Q3 25
49.7%
-4.9%
Q2 25
35.3%
-2.2%
Q1 25
31.7%
-0.3%
Q4 24
38.1%
-6.6%
Q3 24
50.7%
-2.8%
Q2 24
35.0%
2.1%
Q1 24
24.3%
-5.5%
EPS (diluted)
AVB
AVB
CLOV
CLOV
Q4 25
$1.18
Q3 25
$2.68
Q2 25
$1.88
Q1 25
$1.66
Q4 24
$1.99
Q3 24
$2.61
Q2 24
$1.78
Q1 24
$1.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVB
AVB
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$187.2M
$78.3M
Total DebtLower is stronger
$9.3B
Stockholders' EquityBook value
$11.6B
$308.7M
Total Assets
$22.2B
$541.0M
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVB
AVB
CLOV
CLOV
Q4 25
$187.2M
$78.3M
Q3 25
$123.3M
Q2 25
$102.8M
Q1 25
$53.3M
Q4 24
$108.6M
$194.5M
Q3 24
$552.4M
$288.0M
Q2 24
$545.8M
$254.8M
Q1 24
$287.9M
$208.3M
Total Debt
AVB
AVB
CLOV
CLOV
Q4 25
$9.3B
Q3 25
$8.7B
Q2 25
$8.7B
Q1 25
$8.3B
Q4 24
$8.1B
Q3 24
$8.4B
Q2 24
$8.4B
Q1 24
$8.0B
Stockholders' Equity
AVB
AVB
CLOV
CLOV
Q4 25
$11.6B
$308.7M
Q3 25
$11.9B
$340.9M
Q2 25
$11.9B
$344.2M
Q1 25
$11.9B
$336.1M
Q4 24
$11.9B
$341.1M
Q3 24
$11.9B
$342.2M
Q2 24
$11.7B
$324.9M
Q1 24
$11.7B
$292.5M
Total Assets
AVB
AVB
CLOV
CLOV
Q4 25
$22.2B
$541.0M
Q3 25
$21.9B
$559.7M
Q2 25
$21.8B
$575.0M
Q1 25
$21.2B
$583.7M
Q4 24
$21.0B
$580.7M
Q3 24
$21.3B
$653.0M
Q2 24
$21.0B
$674.2M
Q1 24
$20.6B
$671.8M
Debt / Equity
AVB
AVB
CLOV
CLOV
Q4 25
0.80×
Q3 25
0.73×
Q2 25
0.72×
Q1 25
0.70×
Q4 24
0.68×
Q3 24
0.70×
Q2 24
0.71×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVB
AVB
CLOV
CLOV
Operating Cash FlowLast quarter
$1.7B
$-66.9M
Free Cash FlowOCF − Capex
$1.4B
$-69.0M
FCF MarginFCF / Revenue
183.5%
-14.1%
Capex IntensityCapex / Revenue
34.1%
0.4%
Cash ConversionOCF / Net Profit
10.07×
TTM Free Cash FlowTrailing 4 quarters
$2.5B
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVB
AVB
CLOV
CLOV
Q4 25
$1.7B
$-66.9M
Q3 25
$477.0M
$12.1M
Q2 25
$377.8M
$5.4M
Q1 25
$415.9M
$-16.3M
Q4 24
$1.6B
$34.8M
Q3 24
$486.2M
$50.0M
Q2 24
$380.0M
$44.8M
Q1 24
$412.9M
$25.9M
Free Cash Flow
AVB
AVB
CLOV
CLOV
Q4 25
$1.4B
$-69.0M
Q3 25
$402.2M
$11.4M
Q2 25
$317.1M
$4.8M
Q1 25
$367.5M
$-16.5M
Q4 24
$1.4B
$33.3M
Q3 24
$434.2M
$49.6M
Q2 24
$333.0M
$44.4M
Q1 24
$375.4M
$25.5M
FCF Margin
AVB
AVB
CLOV
CLOV
Q4 25
183.5%
-14.1%
Q3 25
52.5%
2.3%
Q2 25
41.7%
1.0%
Q1 25
49.3%
-3.6%
Q4 24
191.0%
9.9%
Q3 24
59.1%
15.0%
Q2 24
45.9%
12.5%
Q1 24
52.7%
7.3%
Capex Intensity
AVB
AVB
CLOV
CLOV
Q4 25
34.1%
0.4%
Q3 25
9.8%
0.1%
Q2 25
8.0%
0.1%
Q1 25
6.5%
0.0%
Q4 24
26.1%
0.5%
Q3 24
7.1%
0.1%
Q2 24
6.5%
0.1%
Q1 24
5.3%
0.1%
Cash Conversion
AVB
AVB
CLOV
CLOV
Q4 25
10.07×
Q3 25
1.25×
Q2 25
1.41×
Q1 25
1.76×
Q4 24
5.70×
Q3 24
1.31×
Q2 24
1.50×
6.04×
Q1 24
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons